PubRank

Brigitte Jude

Author PubWeight™ 60.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 2007 7.19
2 Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003 5.33
3 Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways. Circ Res 2011 2.60
4 Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 2010 2.52
5 In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates? J Thorac Cardiovasc Surg 2007 2.13
6 Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure. Eur Heart J 2011 1.93
7 Liver X receptor activation stimulates iron export in human alternative macrophages. Circ Res 2013 1.66
8 Functional impairment of von Willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction. Circulation 2008 1.56
9 Inferior vena cava agenesis and deep vein thrombosis: 10 patients and review of the literature. Vasc Med 2010 1.56
10 Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure. Am Heart J 2005 1.53
11 Atherosclerotic-like process in aortic stenosis: activation of the tissue factor-thrombin pathway and potential role through osteopontin alteration. Atherosclerosis 2010 1.52
12 Decellularized heart valve as a scaffold for in vivo recellularization: deleterious effects of granulocyte colony-stimulating factor. J Thorac Cardiovasc Surg 2006 1.46
13 Comparison of blood activation in the wound, active vent, and cardiopulmonary bypass circuit. Ann Thorac Surg 2008 1.45
14 Exercise does not enhance the prognostic value of Doppler echocardiography in patients with left ventricular systolic dysfunction and functional mitral regurgitation at rest. Am Heart J 2008 1.40
15 Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest. J Card Fail 2008 1.26
16 Involvement of thrombolysis in recombinant tissue plasminogen activator-induced cerebral hemorrhages and effect on infarct volume and postischemic endothelial function. Stroke 2003 1.14
17 Renal resistance index and its prognostic significance in patients with heart failure with preserved ejection fraction. Nephrol Dial Transplant 2011 1.10
18 High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 2011 1.09
19 The proteome and secretome of human arterial smooth muscle cells. Proteomics 2005 1.02
20 Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1. Eur Heart J 2009 0.96
21 Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial injury and hemostasis in rabbit endotoxic shock. Intensive Care Med 2004 0.93
22 Unlike PPARgamma, PPARalpha or PPARbeta/delta activation does not promote human monocyte differentiation toward alternative macrophages. Biochem Biophys Res Commun 2009 0.93
23 Measuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data. Am Heart J 2011 0.91
24 Impact of valvuloarterial impedance on left ventricular longitudinal deformation in patients with aortic valve stenosis and preserved ejection fraction. Arch Cardiovasc Dis 2010 0.89
25 Quantitative mass spectrometry analysis using PAcIFIC for the identification of plasma diagnostic biomarkers for abdominal aortic aneurysm. PLoS One 2011 0.88
26 Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization. Eur Heart J 2005 0.86
27 Dyslipidemia shifts the tissue factor/tissue factor pathway inhibitor balance toward increased thrombogenicity in atherosclerotic plaques: evidence for a corrective effect of statins. Atherosclerosis 2006 0.86
28 Pretreatment with peroxysome proliferator-activated receptor alpha agonist fenofibrate protects endothelium in rabbit Escherichia coli endotoxin-induced shock. Intensive Care Med 2005 0.85
29 Activated protein C increases sensitivity to vasoconstriction in rabbit Escherichia coli endotoxin-induced shock. Crit Care 2006 0.85
30 Antithrombotic therapy in cardiac surgery. Can J Anaesth 2006 0.85
31 Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques. Atherosclerosis 2008 0.84
32 Prognostic value of hemoglobin decline over the GRACE score in patients hospitalized for an acute coronary syndrome. Heart Vessels 2011 0.83
33 From normal to pathological hemostasis. Can J Anaesth 2006 0.82
34 Inhibition of tissue factor-factor VIIa proteolytic activity blunts hepatic metastasis in colorectal cancer. J Surg Res 2008 0.81
35 The presence of apoptotic bone marrow cells impairs the efficacy of cardiac cell therapy. Cell Transplant 2010 0.80
36 Identification of tissue factor in experimental aortic valve sclerosis. Cardiovasc Pathol 2008 0.79
37 Identification of additional proteins in differential proteomics using protein interaction networks. Proteomics 2013 0.79
38 Frequency of abdominal aortic aneurysm in patients undergoing coronary artery bypass grafting. Am J Cardiol 2010 0.79
39 Dietary lipid lowering modifies plaque phenotype in rabbit atheroma after angioplasty: a potential role of tissue factor. Circulation 2003 0.79
40 Protective effects of basic fibroblast growth factor in early atherosclerosis. Growth Factors 2004 0.78
41 Clinical value of exercise Doppler echocardiography in patients with cardiac-valvular disease. Arch Cardiovasc Dis 2008 0.77
42 Clinical and echocardiographic correlates of plasma B-type natriuretic peptide levels in patients with aortic valve stenosis and normal left ventricular ejection fraction. Echocardiography 2011 0.77
43 Beneficial effects of fenofibrate on plaque thrombogenicity and plaque stability in atherosclerotic rabbits. Cardiovasc Pathol 2008 0.77
44 Fresh frozen plasma use in liver resection. J Am Coll Surg 2003 0.76
45 Free leptin, carotid plaque phenotype and relevance to related symptomatology: insights from the OPAL-Lille carotid endarterectomy study. Int J Cardiol 2013 0.76
46 Tracheal reconstruction with a composite graft: fascial flap-wrapped allogenic aorta with external cartilage-ring support. Interact Cardiovasc Thorac Surg 2012 0.76
47 Experimental off-pump transventricular pulmonary valve replacement using a self-expandable valved stent: A new approach for pulmonary incompetence after repaired tetralogy of Fallot? J Thorac Cardiovasc Surg 2009 0.75
48 The Arg200Trp mutation in the human tissue factor gene. Thromb Haemost 2002 0.75
49 [INR self testing for children: organization modalities and consequences]. Rev Prat 2009 0.75
50 Resistin is independently associated with abdominal aortic aneurysm in severe coronary artery disease patients. Cardiovasc Pathol 2011 0.75
51 Conformational Asn187Asp/Lys antithrombin variants and thrombosis. Clinical and biological features in 13 new heterozygotes. Thromb Haemost 2005 0.75
52 [When to test for thrombophilia?]. Rev Prat 2009 0.75